Carlsmed (CARL) Interest Expenses (2024 - 2026)

Carlsmed (CARL) has reported Interest Expenses for 3 consecutive years, with $10.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest Expenses rose 99.69% year-over-year to $10.3 million; the trailing twelve-month figure through Jun 2026 stood at $41.8 million (up 84.87% YoY), and the FY2025 full-year result was $24.3 million, up 85.83% from the prior year.
• Interest Expenses climbed to $10.3 million in Q2 2026 per CARL's latest filing, from $7.9 million in the prior quarter.
• Across five years, Interest Expenses topped out at $23.2 million in Q4 2025 and bottomed at $325000.0 in Q2 2024.
• Historically, Interest Expenses has averaged $7.2 million across 3 years, with a median of $5.2 million in 2025.
• The widest YoY moves for Interest Expenses: up 1489.23% in 2025, down 5.47% in 2025.
• Over 3 years, Interest Expenses stood at $12.1 million in 2024, then jumped by 91.2% to $23.2 million in 2025, then tumbled by 55.57% to $10.3 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $10.3 million, $7.9 million, and $23.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.